• Company
    • Business model
    • History
    • News / Articles
    • Careers
    • Contact
  • Technology
    • Immobilization
    • Biocatalysis
    • Chiral Separation
    • Chiral Synthesis
    • Enzymatic Process
  • Products
    • Immobeads
      • Beads overview
      • Covalent binding
      • Ionic binding
      • Absorbtion
      • Bead technology
    • Immozymes
      • Product overview
      • Lipases
      • Proteases
      • Other enzymes
      • Genencor
      • Novozymes
      • Immobilization technology
    • Enzymes
      • Genencor
      • Novozymes
      • Other bulk enzymes
      • Special enzymes
      • Biocatalysis
    • Chiral Intermediates
    • Chiral API
    • Services
      • Custom Immobilization
      • Process Development
      • Custom Synthesis
    • Ordering info
  • Markets
    • Chiral Pharma
    • Chiral Intermediates
    • Life Sciences
    • Cosmetics
    • Food / Feed
    • Biofuels
    • Environment

 

 

 

 

 

Company introduction:

 

 

In 2006 it was 400 years ago that Rembrandt van Rijn was born in Leiden. Currently this town is host to a new generation of “Dutch masters”.

 

Dedicated to the application of biocatalysis ChiralVision was founded in 2006, privately funded with headquarters in Leiden, The Netherlands

 

 

 

 

History highlights:

 

2006 - Founding of ChiralVision

2006 - Aquisition of office & labs in Leiden

2006 - Introduction of first Immozymes

2006 - 1st patented custom API process

2007 - Introduction of chiral products

2007 - Various processes developed for food & pharma

2007 - Collaboration with Genencor International

2008 - Products available via Sigma-Aldrich

2008 - 1st Immozyme in API production process

2009 - Over 100 immobilized enzyme products

2010 - Over 60 unique chiral compounds in portfolio

2011 - Aquisition of new office & labs doubling production

          space

 

 

 

Successful business:

 

 

Thanks to its business strategy ChiralVision has managed to become profitable within a short time and has secured a healthy growth of over 25% annually since its first full year of business.

 

Because of its self-sufficientness ChiralVision is capable to remain a flexible business partner and a very competitive player in the present day market while continuing to develop new technologies and products.

 





(C) 2011 ChiralVision B.V.   -  Contact  -  General terms and conditions of sale  -  Disclaimer